Owlet (OWLT) Operating Leases (2022 - 2023)
Owlet (OWLT) reported Operating Leases of $22000.0 for Q4 2023, down 98.11% year-over-year from $1.2 million in Q4 2022, and down 69.44% quarter-over-quarter from $72000.0 in Q3 2023.
Owlet (OWLT) Operating Leases (2022 - 2023) Analysis & Trends
Owlet (OWLT) has 2 years of Operating Leases data on file, last reported at $22000.0 in Q4 2023.
- Operating Leases for Q4 2023 came in at $22000.0, down 98.11% year-over-year; the trailing twelve-month figure through Dec 2023 was $22000.0 (down 98.11% YoY), and the FY2023 annual result was $22000.0, down 98.11% from the prior year.
- Operating Leases retreated to $22000.0 in Q4 2023 per OWLT's latest filing, from $72000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $3.4 million in Q1 2022 and troughed at $22000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 715,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 3.44 Mn |